STOCK TITAN

[Form 4] Illumina Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Illumina insider Steven Barnard, SVP and Chief Technology Officer, reported a sale of 287 shares of Common Stock on 09/05/2025 at a reported price of $98.93 per share, leaving him with 33,546 shares beneficially owned after the transaction. The Form 4 was signed by Robert Maynes on behalf of Mr. Barnard on 09/09/2025. The filing lists no derivative transactions.

Il dirigente di Illumina, Steven Barnard, SVP e Chief Technology Officer, ha venduto 287 azioni Common Stock il 05/09/2025 al prezzo dichiarato di $98.93 per azione, rimanendo con 33.546 azioni di proprietà effettiva dopo l'operazione. Il Modulo 4 è stato firmato da Robert Maynes per conto del Sig. Barnard il 09/09/2025. La comunicazione non riporta operazioni su strumenti derivati.

El directivo de Illumina, Steven Barnard, SVP y Director de Tecnología, vendió 287 acciones de Common Stock el 05/09/2025 a un precio declarado de $98.93 por acción, quedando con 33.546 acciones de propiedad beneficiosa tras la transacción. El Formulario 4 fue firmado por Robert Maynes en nombre del Sr. Barnard el 09/09/2025. La presentación no registra operaciones con derivados.

Illumina의 임원 Steven Barnard(부사장 겸 최고기술책임자)은 2025년 9월 5일보통주 287주를 주당 신고가 $98.93에 매도했으며, 거래 후에 33,546주의 실질적 보유가 남아 있습니다. 양식 4는 2025년 9월 9일에 Robert Maynes가 Barnard 씨를 대신해 서명했습니다. 제출서류에는 파생상품 거래가 기재되어 있지 않습니다.

Le dirigeant d'Illumina, Steven Barnard, SVP et Chief Technology Officer, a vendu 287 actions Common Stock le 05/09/2025 au prix déclaré de 98,93 $ par action, lui laissant 33 546 actions en propriété bénéficiaire après la transaction. Le formulaire 4 a été signé par Robert Maynes au nom de M. Barnard le 09/09/2025. Le dépôt ne mentionne aucune opération sur dérivés.

Illumina-Insider Steven Barnard, SVP und Chief Technology Officer, veräußerte am 05.09.2025 287 Aktien der Common Stock zu einem gemeldeten Kurs von $98,93 je Aktie und verbleibt nach der Transaktion mit 33.546 Aktien im wirtschaftlichen Eigentum. Das Formular 4 wurde am 09.09.2025 von Robert Maynes im Auftrag von Herrn Barnard unterzeichnet. In der Meldung sind keine Derivatgeschäfte aufgeführt.

Positive
  • None.
Negative
  • Officer sold 287 shares of Illumina common stock at $98.93, reducing immediate insider-owned shares.
  • No Rule 10b5-1 plan or other plan is indicated in the filing for this transaction.

Insights

TL;DR: Insider sale of 287 shares at $98.93; holding remains 33,546 shares—routine disclosure with limited market impact.

The reported transaction is a small, open-market sale by a senior executive. The size (287 shares) and proceeds implied by the $98.93 price are modest relative to typical executive holdings, and no derivative activity or additional transactions are disclosed. This filing provides transparency on insider ownership but does not present new operational or financial information about the company.

TL;DR: Form 4 records a routine disposition by an officer; disclosure complies with Section 16 reporting requirements.

From a governance perspective, the Form 4 is complete for the disclosed non-derivative sale: it identifies the reporting person, relationship to the issuer, transaction date, price, amount sold, and post-transaction beneficial ownership. There is no indication of a Rule 10b5-1 plan or any amendment; no governance concerns are evident from this single, small sale.

Il dirigente di Illumina, Steven Barnard, SVP e Chief Technology Officer, ha venduto 287 azioni Common Stock il 05/09/2025 al prezzo dichiarato di $98.93 per azione, rimanendo con 33.546 azioni di proprietà effettiva dopo l'operazione. Il Modulo 4 è stato firmato da Robert Maynes per conto del Sig. Barnard il 09/09/2025. La comunicazione non riporta operazioni su strumenti derivati.

El directivo de Illumina, Steven Barnard, SVP y Director de Tecnología, vendió 287 acciones de Common Stock el 05/09/2025 a un precio declarado de $98.93 por acción, quedando con 33.546 acciones de propiedad beneficiosa tras la transacción. El Formulario 4 fue firmado por Robert Maynes en nombre del Sr. Barnard el 09/09/2025. La presentación no registra operaciones con derivados.

Illumina의 임원 Steven Barnard(부사장 겸 최고기술책임자)은 2025년 9월 5일보통주 287주를 주당 신고가 $98.93에 매도했으며, 거래 후에 33,546주의 실질적 보유가 남아 있습니다. 양식 4는 2025년 9월 9일에 Robert Maynes가 Barnard 씨를 대신해 서명했습니다. 제출서류에는 파생상품 거래가 기재되어 있지 않습니다.

Le dirigeant d'Illumina, Steven Barnard, SVP et Chief Technology Officer, a vendu 287 actions Common Stock le 05/09/2025 au prix déclaré de 98,93 $ par action, lui laissant 33 546 actions en propriété bénéficiaire après la transaction. Le formulaire 4 a été signé par Robert Maynes au nom de M. Barnard le 09/09/2025. Le dépôt ne mentionne aucune opération sur dérivés.

Illumina-Insider Steven Barnard, SVP und Chief Technology Officer, veräußerte am 05.09.2025 287 Aktien der Common Stock zu einem gemeldeten Kurs von $98,93 je Aktie und verbleibt nach der Transaktion mit 33.546 Aktien im wirtschaftlichen Eigentum. Das Formular 4 wurde am 09.09.2025 von Robert Maynes im Auftrag von Herrn Barnard unterzeichnet. In der Meldung sind keine Derivatgeschäfte aufgeführt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Barnard Steven

(Last) (First) (Middle)
5200 ILLUMINA WAY

(Street)
SAN DIEGO CA 92122

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ILLUMINA, INC. [ ILMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Chief Technology Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/05/2025 F 287 D $98.93 33,546 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
By: Robert Maynes for Steven Barnard 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Steven Barnard report on Form 4 for ILMN?

He reported a sale of 287 shares of Illumina common stock on 09/05/2025 at a price of $98.93, leaving 33,546 shares beneficially owned.

Does the Form 4 show any derivative transactions for Steven Barnard (ILMN)?

No. The filing shows only a non-derivative sale of common stock and explicitly lists no derivative securities.

When was the Form 4 signed and filed for this transaction?

The signature block shows the form was signed by Robert Maynes for Steven Barnard on 09/09/2025.

What is Steven Barnard's role at Illumina as listed on the Form 4?

He is listed as SVP, Chief Technology Officer and an officer of the issuer.

How many shares did Steven Barnard own after the reported sale?

He beneficially owned 33,546 shares following the reported transaction.
Illumina Inc

NASDAQ:ILMN

ILMN Rankings

ILMN Latest News

ILMN Latest SEC Filings

ILMN Stock Data

15.09B
153.39M
0.19%
102.89%
4.88%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
SAN DIEGO